Slade Health has expanded its laboratory services, increasing testing capacity and enhancing our ability to support customers through every stage of the product lifecycle.
The investment reflects our ongoing commitment to quality, innovation and delivering reliable services that support safe patient care.
The upgraded laboratory strengthens our capability to manage stability studies more efficiently while maintaining the high standards of quality and compliance our customers expect. As demand for specialist testing services continues to grow, the expansion will help support both current and future service requirements across the Slade Health network.
As part of the upgrade, Slade Health has introduced in-house Microbial Identification (Micro ID) testing to support compounding centre operations and environmental monitoring programs. Bringing this capability in-house provides increased testing capacity, improved laboratory controls and enhanced oversight of microbial monitoring activities.
Together, these enhancements strengthen our ability to deliver responsive, high-quality laboratory services while supporting operational excellence and regulatory compliance across our facilities. As we continue to invest in our capabilities, our focus remains on providing trusted solutions that help our customers deliver the best possible outcomes for patients.
